We are increasingly able to turn to non-surgical therapies for structural and valvular heart disease. Host Dr. Lee Freedman discusses investigational, catheter-based treatment with Dr. Howard Herrmann, professor of medicine, and director of interventional cardiology and the Cardiac Catheterization Laboratories within the University of Pennsylvania Health System. What new devices are making these advances possible? What are the procedural risks?
ReachMD
Be part of the knowledge.™Investigational Approaches to Structural and Valvular Heart Disease
Choose a format
Media formats available:
Facebook Comments